Document/Article
-
Types
Public Health Agency of Canada
This study aimed to provide the first national estimates of HBV prevalence and unawareness, and to update estimates of HCV incidence, prevalence, and unawareness in the general population and key populations in Canada for 2021. Progress towards elimination targets for 2025, namely incidence, awareness, mortality, and HBV vaccination, was also assessed
-
Resource CategoriesTypes
Treatment Access Group (TAG)
Welcome to the 2025 Pipeline Report. TAG’s annual review provides an overview of research and development of innovations for diagnosing, preventing, treating, and curing HIV, hepatitis C virus (HCV), and tuberculosis (TB).
-
Types
GetCheckedOnline Team (BCCDC)
-
Resource CategoriesTypes
Government of Canada
This data blog presents information about stigma and discrimination in people who inject drugs in Canada (Phase 5 Tracks survey, 2024)
-
Resource CategoriesTypes
CATIE
-
Resource CategoriesTypes
CTN+
This document was created by the CTN+ Community Leadership Team to ensure transparency and support community members in making informed decisions about their involvement with CTN+ work.
-
Types
Network of Networks
Clinical trials play a pivotal role in advancing medical research and shaping the future of healthcare by evaluating the safety and efficacy of new treatments andinterventions. However, ensuring diverse participation in these trials is essential to truly understand how treatments work across different populations. By includingindividuals from diverse backgrounds, including various racial, ethnic, socioeconomic, and…
-
Resource CategoriesTypes
Canadian Pediatric & Perinatal HIV/AIDS Research Group
While exclusive formula feeding remains the preferred recommendation for infants born to women living with HIV in high-income countries, a more nuanced approach that may include the option of breastfeeding under certain circumstances is emerging in many resource-rich countries.